Literature DB >> 19689736

A central role for monocytes in Toll-like receptor-mediated activation of the vasculature.

Jon R Ward1, Sheila E Francis, Luke Marsden, Tesha Suddason, Graham M Lord, Steven K Dower, David C Crossman, Ian Sabroe.   

Abstract

There is increasing evidence that activation of inflammatory responses in a variety of tissues is mediated co-operatively by the actions of more than one cell type. In particular, the monocyte has been implicated as a potentially important cell in the initiation of inflammatory responses to Toll-like receptor (TLR)-activating signals. To determine the potential for monocyte-regulated activation of tissue cells to underpin inflammatory responses in the vasculature, we established cocultures of primary human endothelial cells and monocytes and dissected the inflammatory responses of these systems following activation with TLR agonists. We observed that effective activation of inflammatory responses required bidirectional signalling between the monocyte and the tissue cell. Activation of cocultures was dependent on interleukin-1 (IL-1). Although monocyte-mediated IL-1beta production was crucial to the activation of cocultures, TLR specificity to these responses was also provided by the endothelial cells, which served to regulate the signalling of the monocytes. TLR4-induced IL-1beta production by monocytes was increased by TLR4-dependent endothelial activation in coculture, and was associated with increased monocyte CD14 expression. Activation of this inflammatory network also supported the potential for downstream monocyte-dependent T helper type 17 activation. These data define co-operative networks regulating inflammatory responses to TLR agonists, identify points amenable to targeting for the amelioration of vascular inflammation, and offer the potential to modify atherosclerotic plaque instability after a severe infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19689736      PMCID: PMC2747139          DOI: 10.1111/j.1365-2567.2009.03071.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  The role of immune activation in endotoxin-induced atherogenesis.

Authors:  C J Wiedermann; S Kiechl; P Schratzberger; S Dunzendorfer; G Weiss; J Willeit
Journal:  J Endotoxin Res       Date:  2001

2.  Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.

Authors:  Kristina Edfeldt; Jesper Swedenborg; Göran K Hansson; Zhong-qun Yan
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

3.  Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study.

Authors:  C J Wiedermann; S Kiechl; S Dunzendorfer; P Schratzberger; G Egger; F Oberhollenzer; J Willeit
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

4.  Rapid secretion of interleukin-1beta by microvesicle shedding.

Authors:  A MacKenzie; H L Wilson; E Kiss-Toth; S K Dower; R A North; A Surprenant
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

5.  Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation.

Authors:  S Sasu; D LaVerda; N Qureshi; D T Golenbock; D Beasley
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

6.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.

Authors:  Ian Sabroe; Elizabeth C Jones; Lynne R Usher; Moira K B Whyte; Steven K Dower
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

9.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

10.  A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains.

Authors:  Lisa C Parker; Elizabeth C Prestwich; Jon R Ward; Elizabeth Smythe; Anthony Berry; Martha Triantafilou; Kathy Triantafilou; Ian Sabroe
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

View more
  15 in total

1.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

2.  Diesel exhaust particles override natural injury-limiting pathways in the lung.

Authors:  N Chaudhuri; C Paiva; K Donaldson; R Duffin; L C Parker; I Sabroe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-30       Impact factor: 5.464

3.  Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.

Authors:  Yifan Ma; Louis Poisson; Guzman Sanchez-Schmitz; Santosh Pawar; Chunfeng Qu; Gwendalyn J Randolph; William L Warren; Eric M Mishkin; Russell G Higbee
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice.

Authors:  Arun Prakash; Kailin R Mesa; Kevin Wilhelmsen; Fengyun Xu; Jeffrey M Dodd-o; Judith Hellman
Journal:  Anesthesiology       Date:  2012-10       Impact factor: 7.892

5.  Heme stimulates platelet mitochondrial oxidant production to induce targeted granule secretion.

Authors:  Gowtham K Annarapu; Deirdre Nolfi-Donegan; Michael Reynolds; Yinna Wang; Lauryn Kohut; Brian Zuckerbraun; Sruti Shiva
Journal:  Redox Biol       Date:  2021-12-05       Impact factor: 11.799

6.  Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines.

Authors:  Alexander Basran; Maisha Jabeen; Lynne Bingle; Clare A Stokes; David H Dockrell; Moira K B Whyte; Sarah R Walmsley; Kathryn R Higgins; Stefanie N Vogel; Heather L Wilson; Lynne R Prince; Elizabeth C Prestwich; Ruth A Sabroe; Lisa C Parker; Ian Sabroe
Journal:  J Leukoc Biol       Date:  2012-08-17       Impact factor: 4.962

7.  Pellino-1 selectively regulates epithelial cell responses to rhinovirus.

Authors:  Julie A Bennett; Lynne R Prince; Lisa C Parker; Clare A Stokes; Harold G de Bruin; Maarten van den Berge; Irene H Heijink; Moira K Whyte; Ian Sabroe
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

8.  Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection.

Authors:  Clare A Stokes; Saila Ismail; Emily P Dick; Julie A Bennett; Sebastian L Johnston; Michael R Edwards; Ian Sabroe; Lisa C Parker
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 9.  Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.

Authors:  Andrzej Lange; Janusz Lange; Emilia Jaskuła
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

10.  Neutrophil elastase promotes interleukin-1β secretion from human coronary endothelium.

Authors:  Mabruka Alfaidi; Heather Wilson; Marc Daigneault; Amanda Burnett; Victoria Ridger; Janet Chamberlain; Sheila Francis
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.